PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Combined ethinylestradiol 30mcg
Presentation Product Chemical substance Chapter Items dispensed
Ethinylestradiol 30microg / Levonorgestrel 150microg tab
0703010F0AAACAC
Combined ethinylestradiol 30mcg Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 37,031
Ethinylestradiol 30microgram / Drospirenone 3mg tablets
0703010F0AAAJAJ
Combined ethinylestradiol 30mcg Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 14,222
Ethinylestradiol 30microgram / Desogestrel 150microgram tab
0703010F0AAAAAA
Combined ethinylestradiol 30mcg Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 8,845
Ethinylestradiol 30microgram / Gestodene 75microgram tablets
0703010F0AAAEAE
Combined ethinylestradiol 30mcg Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 1,870
Ethinylestradiol 30microg / Norethisterone acetate 1.5mg tab
0703010F0AAAFAF
Combined ethinylestradiol 30mcg Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 8
Generic Microgynon 30 ED tablets
0703010F0AAAHAH
Combined ethinylestradiol 30mcg Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 1
Generic Femodene ED tablets
0703010F0AAAGAG
Combined ethinylestradiol 30mcg Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Levonorgestrel 250microg / Ethinylestradiol 30microg tab
0703010F0AAABAB
Combined ethinylestradiol 30mcg Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.